Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate (PR Newswire via Yahoo! Finance)
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. , today announced that the U.S. Food and Drug Administration has granted final approval of the company's New Drug Applications for its extended- release and immediate-release formulations of oxymorphone hydrochloride.

Amazon Biotech Phase I/II HIV Clinical Trial Protocol Receives FDA "Green Light" (SYS-CON Media)
Amazon Biotech, Inc. (OTCBB: AMZBE) (FRANKFURT: B2D) announced today that it has successfully negotiated a phase I/IIprotocol with the FDA. This allows Amazon Biotech to move forward withimplementation of its filed Phase I/II trial of its proprietary AMZ0026therapy in HIV Positive patients.

Update: HealthSonix Registers AquaSonix Medical Device With the FDA (SYS-CON Media)
HealthSonix Inc. ('HealthSonix' or the 'Company')(PINKSHEETS: HSXI) www.HealthSonix.com, is pleased to announce that it hasregistered the AquaSonix medical device with the United States Food andDrug Administration (FDA). Indications are for pain reduction and musclerelaxation. The device was designated as class 1, the safest classificationfor medical devices.